Global Hepatitis C Elimination: Experience and the Road Ahead

Time & Date: AM 09:00-12:00, Monday, 18 May 2026

Venue: Ballroom, Hotel President Wilson, Geneva

Overview:

The World Health Organization (WHO) has charted an ambitious mandate to eliminate viral hepatitis as a public health threat by 2030. Despite significant global strides, Hepatitis B and C continue to impose a staggering burden on global health systems, with systemic disparities in diagnosis and treatment access remaining a critical barrier to achieving universal health equity.

In proactive alignment with these global priorities, Taiwan has spearheaded the “Taiwan Hepatitis C Policy Guideline 2018–2025.” This framework is anchored by three core strategies: “Precision Public Health,” “Localized Care Delivery,” and an “Continuum of Care.” This approach is further operationalized through a synergistic policy triad: “Therapy Spearheads Prevention,” “Screening Supports Therapy,” and “Prevention Secures Outcomes.”

Through these rigorous interventions, Taiwan successfully reached its elimination targets in 2025, attaining this milestone five years ahead of the WHO’s 2030 schedule. Taiwan’s national performance has surpassed the WHO Path to Elimination “Gold Tier” standards, maintaining diagnosis and treatment rates exceeding 90% while achieving 100% coverage in injection safety and blood screening efficacy.

Against the backdrop of the 79th World Health Assembly, the Ministry of Health and Welfare (MOHW), Taiwan, will convene a high-level strategic forum to catalyze multilateral knowledge exchange among international experts and stakeholders. This event serves as a premier platform to synthesize transformative health models and collectively navigate the complexities of the post-elimination landscape.

The forum will feature a comprehensive exploration of scalable success stories and the pivotal role of civil society, while addressing the strategic imperatives of maintaining sustainability in the post-elimination era. By synergizing national and international action plans toward 2030, we aim to provide a decisive contribution to the worldwide mission of securing a hepatitis-free future.

We cordially invite the global health community to join us in this critical dialogue as we re-affirm our unwavering commitment to global health security.